COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- The prevalence of any alcohol use and heavy alcohol use was higher in 2020 and 2022 compared with 2018, according to a research letter published online Nov. 12 in the Annals of Internal Medicine.
Divya Ayyala-Somayajula, M.D., from the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, and colleagues examined whether increased alcohol use during the pandemic (2020 versus 2018) was sustained after the pandemic (2022) using cross-sectional data from serial nationally representative surveys of adults who participated in the National Health Interview Survey. The analyses included 24,965 respondents from 2018, 30,829 from 2020, and 26,806 from 2022.
The researchers observed absolute increases in any alcohol use in 2020 and 2022 compared with 2018 (2.69 and 2.96 percent, respectively). In 2020 and 2022 versus 2018, there were numerical increases seen in any alcohol use among all subgroups. Absolute increases in heavy alcohol use were noted in 2020 and 2022 versus 2018 (1.03 and 1.18 percent, respectively), with numerical increases seen among all subgroups except American Indians and Asians in 2022.
"Our results highlight an alarming public health issue that may require a combination of policy changes," the authors write. "Increased screening efforts for harmful drinking with systematic integration and rapid linkage to behavioral health treatments by health care professionals, in tandem with community-based interventions for at-risk populations, should be considered to mitigate the public health consequences of the pandemic-related increase in alcohol use."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-13 06:00
Read more
- 'Ableism' Prevents Many Americans From Getting Mental Health Care
- U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome
- Model Including Polygenic Risk, Polysocial Score Improves CHD Risk Prediction
- Inflammatory Bowel Disease on the Rise Globally in the Elderly
- Syros Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression
- Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions